Ambitious PR Competitors

PharmaS was founded in 2008 in Zagreb, Croatia. It is present in most SEE markets and currently has operations across seven countries. Its pharma business includes a vast portfolio of Rx retail and hospital products, as well as OTC drugs. In addition, PharmaS is a leading player in the Adria region in consumer healthcare, having acquired Dietpharm portfolio back in 2019. In 2023 PharmaS acquired Madrid-based MABO-FARMA and started expansion into western European markets on its strategic path to become a pan-European pharma company focused on commercialization of drugs, utilizing and further developing its partnership network. PharmaS currently employs around 400 experts with over 150 customer-facing staff in commercial operations covering SEE markets and Spain, allowing for cooperation with various pharmaceutical companies, both innovative and generic, in regard to manufacturing or marketing a wide portfolio of molecules. Besides a strong marketing and sales teams across territories, PharmaS owns three modern pharmaceutical factories with capacity exceeding 30 million packages per year. Its manufacturing facilities are located in Zagreb, Rakitje (Croatia) and Zrenjanin (Serbia). The company’s production, storage, distribution and drug quality control processes meet the strictest EU standards set for the pharmaceutical industry. PharmaS applies the best pharmaceutical practices, all procedures meet the GMP (Good Manufacturing Practice) standards, and has held an ISO 21000:2005 certificate as of this year, which it uses to meet the HACCP standard as this is very important with respect to food supplement production. The company regularly receives the highest ratings from auditors and regulatory authorities. The level of quality is evident from the fact that PharmaS is the first Croatian pharmaceutical company that has been inspected under TAIEX, an EU program, and was awarded excellent ratings.

Diffusion is an independent, global communications agency that exists to bring tomorrow closer. We help innovators, challengers and ambitious organisations take on the status quo, turning complex ideas into compelling campaigns that create markets, build trust and drive business growth. Our international team blends deep sector expertise with bold, creative storytelling across PR, marketing, social and lead generation. We connect our clients with the investors, policymakers, customers and audiences that matter most. Diffusion works with technology innovators, scientific pioneers, cleantech leaders and consumer brands shaping the future of their industries. Whatever the business challenge, we believe creative communication is a catalyst for change. Founded in 2008, Diffusion operates wholly owned offices in London, New York and Los Angeles, with an agency partner network spanning the globe.

ADL BioPharma’s experience in a leading position in the biopharmaceutical industry spans 6 decades. The company’s activity is mostly centred on two pivots: the development and production of active therapeutic substances (mainly beta-lactam active ingredients), and the development and manufacture on contract of products and intermediates obtained from fermentation processes for third parties in the food, cosmetic and biotechnology industries. What we offer The R&D, Quality and Production Units at ADL BioPharma offer comprehensive support for our customer’s projects, from the development of the process to its industrial scaling up, complying, upon demand, with the requirements established by the Good Manufacturing Practice system (GMP). We carry out projects that go from minimum amounts measured in grams to several tons, providing technical support throughout and in strict compliance with the applicable regulations.